Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2025-12-24 @ 1:37 PM
NCT ID:
NCT05222295
Eligibility Criteria:
Inclusion Criteria:
* Volunteering to participate in the study
* Being diagnosed with C and D group COPD according to GOLD (Global iniative for chronic Obstructive Lung Disease) staging
* Not using an assistive device
* Using the same drugs for the last 4 weeks
* Permission to participate in the exercise for the patient from the responsible physician
* Getting a score of 24 or higher in the Standardized Mini Mental State Examination (MMDM)
* Absence of additional comorbid diseases of the orthopedic, neurological, cardiac system
* Having a score of 30 or higher on each of the Kinesthetic and Visual Imagery Questionnaire -20 (KGIA-20) visual imagery score and kinesthetic imagery score
Exclusion Criteria:
* Refusing to participate in the study
* Presence of respiratory system disease other than COPD
* Contraindication for moderate-intensity exercise (eg, unstable heart disease or stage 2 hypertension)
* Being an active smoker
* Patients who have had an acute exacerbation of COPD in the last 4 weeks
* Patients who have used oral corticosteroid drugs in the last 4 weeks
* Internet, computer, etc. patients who do not have technological equipment
* Patients who had a COPD exacerbation during the study protocol
* Participants who cannot understand verbal instructions and are visually impaired
* Having participated in another clinical trial within the last 30 days and currently that could affect the results of the trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT05222295
Study Brief:
Protocol Section:
NCT05222295